Skip to main content
Have a personal or library account? Click to login
OLAPARIB: A promising PARP Inhibitor for the treatment of ovarian cancer Cover

OLAPARIB: A promising PARP Inhibitor for the treatment of ovarian cancer

Forum of Clinical Oncology
Volume 6 (2015): Issue 3 (September 2015)
By: Nikolaos Soupos,  Konstantinos Laschos,  Evangelos Bournakis,  Euthymios Kostouros and  Gerasimos Aravantinos  
Open Access
|Dec 2015
Authors

Authors

Nikolaos Soupos

nsoupos@yahoo.gr

Konstantinos Laschos

Evangelos Bournakis

Euthymios Kostouros

Gerasimos Aravantinos

DOI: https://doi.org/10.1515/fco-2015-0014 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 1 - 7
Submitted on: Sep 18, 2015
Accepted on: Sep 30, 2015
Published on: Dec 17, 2015
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
PARP-inhibitors,
Olaparib,
Ovarian Cancer
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2015 Nikolaos Soupos, Konstantinos Laschos, Evangelos Bournakis, Euthymios Kostouros, Gerasimos Aravantinos, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 6 (2015): Issue 3 (September 2015)
Next article